Roche, Ionis herald a big win in early-stage Huntington’s disease trial, demonstrate disease modifying potential
Ionis $IONS and its partners at Roche have unveiled the biomarker data from a Phase I/II study that recently drove the pharma giant to follow …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
